First Trust Nasdaq PharmaceuFTXHETF
13F holders, Q1 2025 (March 31)20holders −1
2new positions
3sold out
1famous investor
$27.49avg. 13F price*
At the end of Q1 2025, 20 institutions reported holding First Trust Nasdaq Pharmaceu (FTXH) in their 13F filings, down 1 from Q4 2024. 2 opened new positions and 3 sold out. The largest holders were LPL Financial LLC ($2.9M), Goldman Sachs Group Inc. ($535K) and Envestnet Asset Management Inc. ($517K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- First Trust Nasdaq Pharmaceu
- CUSIP
- 33738R837
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $652K |
| Exits | 3 | $1.3M |
All 13F filers, Q4 2024 → Q1 2025: 86,123 shares bought and 54,152 shares sold, net +31,971 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| LPL Financial LLC | 0.00% | Add +87.7% | 104,902 | $2.9M |
| Goldman Sachs Group Inc. | 0.00% | Add +11.8% | 19,472 | $535K |
| Envestnet Asset Management Inc. | 0.00% | Add +14.6% | 18,799 | $517K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | Add +19.1% | 16,567 | $455K |
| Old Mission Capital LLC | 0.01% | New | 15,740 | $433K |
| Ameritas Investment Partners, Inc. | 0.01% | Add +8.1% | 15,320 | $421K |
| WMG Financial Advisors, LLC | 0.15% | Reduce -3.0% | 12,895 | $354K |
| Debussy Capital Management LP | 0.05% | Add +28.1% | 11,120 | $306K |
| Citadel Advisors | 0.00% | New | 7,961 | $219K |
| Morgan Stanley | 0.00% | Reduce -0.4% | 5,915 | $163K |
| Bank of Montreal | 0.00% | No change | 4,888 | $134K |
| Osaic Holdings, Inc. | 0.00% | Add +53.0% | 3,748 | $103K |
| Steward Partners Investment Advisory, LLC | 0.00% | Reduce -58.7% | 3,410 | $94K |
| UBS Group AG | 0.00% | Add +93.2% | 2,906 | $80K |
| Lanark Financial, Inc. | 0.00% | — | 1,075 | $29K |
| Harbour Investments, Inc. | 0.00% | No change | 836 | $23K |
| Asset Dedication, LLC | 0.00% | No change | 593 | $16K |
| Capital Investment Advisory Services, LLC | 0.00% | No change | 450 | $12K |
| IFP Advisors, Inc | 0.00% | No change | 307 | $8K |
| Wells Fargo & Company | 0.00% | No change | 1 | $29 |
"% of holder's portfolio" is FTXH's weight in each manager's 13F, not the share of First Trust Nasdaq Pharmaceu the manager owns.